<DOC>
	<DOC>NCT00517868</DOC>
	<brief_summary>A double-blind, placebo-controlled study to evaluate changes in pain, urgency and urinary frequency following administration of URG101 compared to placebo.</brief_summary>
	<brief_title>Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Pain</mesh_term>
	<mesh_term>Cystitis</mesh_term>
	<mesh_term>Cystitis, Interstitial</mesh_term>
	<criteria>male and female subjects &gt;= 18 years of age moderate to severe symptoms of PBS/IC minimum pain/urgency/frequency scores female subjects on hormone therapy must be on stable dose for &gt;= 3 months positive pregnancy test or pregnant or lactating narcotics or medical marijuana within 3 months use of any investigational drug or device within 30 days bacterial cystitis within 30 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>bladder</keyword>
	<keyword>pain</keyword>
	<keyword>urgency</keyword>
	<keyword>frequency</keyword>
</DOC>